“The brain is one of the most complex things in the universe and our understanding of it is still limited. There is a lot for us to learn and translate that learning into clinical practice,” said Professor John Geddes, director of research and development at Oxford Health NHS FT, as he launched the event to a full audience.
The day, which was open to all patients, carers, clinical staff and researchers, included talks that revealed cutting-edge treatments that are currently in development such as wearable technology for monitoring bipolar disorder, and the use of Ketamine for treatment-resistant depression.
The effectiveness of mindfulness-based interventions was explored by Dr Willem Kuyken, director of the Oxford Mindfulness Centre, while Dr Jane Fossey revealed the significant insights her team’s Well being and Health for People with Dementia (WHELD) study had gained into optimising care for people living with dementia in care homes. In a moving video, care staff shared their experiences of taking part in WHELD. They discussed how the programme had helped them to connect more positively with patients and bring greater meaning to their roles and the lives of their patients.
People who attended the day’s talks commented: “I loved everyone’s enthusiasm for improving healthcare, and the presentations were accessible to all.”
The trust remains one of the UK’s leading organisations in terms of mental health research. Over the past three years, it has conducted over 1200 research projects, recruited over 80,000 participants and published almost 1700 peer-reviewed studies. At the moment, one in ten patients is recruited into research. “We still need to drive more patient participation,” said Professor Geddes, “as we know that it’s good for patient care overall.”
To find out more visit: www.oxfordhealth.nhs.uk/research
If you are interested in taking part in research please email: Mentalhealth.email@example.com